Moteur de recherche d’entreprises européennes
Financement de l’UE (3 285 662 €) : Cristallisation vers une biofabrication efficace et durable Hor23/07/2024 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Cristallisation vers une biofabrication efficace et durable
"Downstream processing (DSP) of biopharmaceuticals is dominated by chromatographic steps which suffer from low throughput, poor scalability and elevated energy consumption, as well as high equipment and materials costs. To this is added the low stability and high degradability of liquid formulations. The training program ""Crystallisation towards efficient and sustainable biomanufacturing"" (PROCRYSTAL) vision is that of crystallisation as a simple, sustainable, cost-efficient and scalable alternative to current DSP techniques and liquid formulations, once it allows to separate, purify and stabilise in a single step. Nevertheless, integrated training to exploit biocrystallisation full potential is currently not available, only fragmented research activities. Within this training program, 13 Doctoral candidates (DCs) are expected to go beyond current practise to respond to the near future biopharma manufacturing needs. And only possible leveraged by the expertise conveyed in this consortium on biomolecules crystallisation, biochemistry, chemical and process engineering as well as advanced modelling. The PROCRYSTAL training program for the DCs has been framed with special attention to fundamental understanding of the underlying phenomena, from the molecular scale to process scale, and advanced experimental and modelling techniques specific to crystallisation technology. The DCs will acquire a wide range of subject specific and general transferable skills, in an interdisciplinary and inter-sectoral environment and by multinational collaboration which enhances the early-career DCs long term employability and competitiveness. "
| EOS Srl | ? |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | 503 942 € |
| BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM | 228 348 € |
| Centre National de la Recherche Scientifique CNRS | 565 387 € |
| Chimikotechnologitchen I Metalurgitchen Universitet | 207 295 € |
| Janssen Pharmaceutica N.V. | 262 620 € |
| Katholieke Universiteit Leuven | 262 620 € |
| Secoya Technologies | 262 620 € |
| Universidade do Minho | 730 210 € |
| Vrije Universiteit Brussel | 262 620 € |
https://cordis.europa.eu/project/id/101169471
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : EOS Srl, Canegrate, Italie.